Project Grant R01DK148406
Award Date 8/25/26
Completion Date 5/31/30
Dollars Obligated $785K
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Seattle, WA 98195, USA
Similar Awards
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded the University of Washington $810,834 on September 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847, Assistance Listing Project Grant R01DK145010). The award funds an ancillary study that integrates advanced retinal imaging into the Kidney Precision Medicine Project, a national NIDDK-funded cohort study of people with diabetes and/or hypertension. The research aims...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded the University of Washington $192,763 on March 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), a Project Grant supporting basic and clinical biomedical research that improves understanding of disease mechanisms and leads to improved prevention, diagnosis, and treatment. The award funds a prospective nested cohort study investigating mechanisms of kidney...
- Federal Grant Award Summary The University of Washington received a $404,883 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 1, 2025, through August 31, 2027. The grant funds the development and optimization of advanced spatial transcriptomics and proteomics technologies for studying kidney disease mechanisms. The project will produce...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded The Washington University $766,951 on April 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to develop and validate imaging biomarkers for assessing high-risk deceased donor kidneys slated for transplantation. The project addresses kidney shortage by improving the accuracy of kidney quality assessment, reducing the approximately 2,500 procured kidneys discarded...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Panluminate Inc. $354,958 on August 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to develop and validate the PAN-EXM Renal Pathology Platform, an AI-enabled diagnostic system for podocytopathies including focal segmental glomerulosclerosis, membranous nephropathy, and minimal change disease. Panluminate will deliver three core products over the 30-month period...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded The Washington University $388,750 on April 23, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to investigate the structural and functional mechanisms of podocin in glomerular membrane organization and kidney disease. The research applies detergent-free, vesicle-based cryo-electron microscopy to determine the full-length structure of podocin at near-atomic resolution...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded the University of Washington $839,388 on August 15, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to develop engineered human liver tissue for heterotopic transplant and therapeutic rescue of liver disease. The project addresses the critical shortage of donor organs for patients with end-stage liver disease by developing cultured human hepatocytes as organoids that...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Massachusetts Institute of Technology $837,398 on July 10, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to develop a label-free imaging platform for mapping lipid-mitochondrial interactions in the enteric nervous system across the lifespan and in disease states. The recipient will integrate a deep metabolic imaging microscope with time-resolved detection and...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded the University of Washington $888,773 on April 15, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847, Project Grant R01DK140210). The award funds research defining the contributions of hypothalamic microglia and perineuronal nets to obesity pathogenesis. The project investigates inflammatory activation of hypothalamic microglia in the arcuate nucleus and the loss of...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded the University of Washington $825,905 on March 6, 2026, to develop an immunocompetent colon chip platform for modeling Crohn's disease under CFDA 93.847 (Diabetes, Digestive, and Kidney Diseases Extramural Research). The award funds construction of a three-dimensional intestinal platform incorporating primary intestinal and immune cells to model the colonic microenvironment in both health and disease. The platform...